CD4 and AIDS: This method relies in part on assumptions of uniform parameters for disease progression markers such as the onset of AIDS symptoms or the proportion of newly diagnosed individuals with CD4 cell count less than 200 cells/μl, although variation in the rate of decline of CD4 cell count over time and across gender, ethnicity, and HIV subtypes undermines the validity of this method [72]–[74].